当代临床实践中孤立性三尖瓣手术的结局
该回顾性队列研究纳入2013至2019年在本机构接受孤立性三尖瓣手术的43例患者,评估临床结局与功能容量。90天内无死亡,主要并发症为4例需植入起搏器和1例需2次再手术;1年内4例死亡。存活超过1年的39例患者中,随访时97.4%为纽约心脏协会I或II级,较术前30.8%显著改善(P=0.001),水肿与利尿剂治疗强度亦显著降低。作者认为孤立性三尖瓣手术可安全实施并大幅改善功能状态,支持优化手术时机与患者选择的重要性。
要点
- 90天内无死亡,主要并发症为4例(9.3%)需起搏器植入和1例需2次再手术。
- 1年内4例(9.3%)死亡,中位随访38.4个月期间9例(20.1%)因心脏原因单次再入院。
- 存活超过1年者随访时97.4%为纽约心脏协会I或II级,术前为30.8%(P=0.001)。
核心结论
- 作者认为孤立性三尖瓣手术可安全实施并大幅改善患者功能状态,其发现支持优化手术时机与患者选择的重要性。
研究设计与样本
- 回顾性队列研究,纳入2013至2019年在本机构接受孤立性三尖瓣手术的全部患者,队列通过西丹麦心脏登记处识别,术后结局通过患者病历评估,对存活超过1年者报告临床与超声心动图状态。
- 共纳入43例患者,平均年龄65.2±13.8岁,欧洲心脏手术风险评估系统II中位数1.8(四分位距2.0),12例(27.9%)有既往心脏手术史。
主要发现
- 至90天随访无患者死亡,主要并发症限于4例(9.3%)需植入起搏器和1例需2次再手术。
- 1年内4例(9.3%)死亡;在中位随访38.4个月(四分位距30.9个月)期间,9例(20.1%)因心脏原因需单次再入院。
- 存活超过1年的全部39例完成临床随访;随访时38/39(97.4%)为纽约心脏协会I或II级,术前为12/39(30.8%)(P=0.001)。
- 水肿存在与利尿剂治疗强度显著降低(分别为P=0.005和P=0.008)。
- 超声心动图随访显示所有患者三尖瓣功能障碍显著改善。
临床怎么用
- 原文未据此给出推荐,作者结论指出其结果提示孤立性三尖瓣手术可安全实施并大幅改善功能状态,支持优化手术时机与患者选择的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Isolated tricuspid valve (TV) surgery is rarely performed and has been associated with high mortality and morbidity. The aim of this study was to describe the clinical outcome and functional capacity following isolated TV surgery in contemporary practice. METHODS: We conducted a retrospective cohort study including all patients who underwent isolated TV surgery at our institution from 2013 to 2019. Our cohort was identified using the Western Denmark Heart Registry. Postoperative outcomes were evaluated using patients' medical records. The clinical and echocardiographic status was reported for patients who survived beyond 1 year. RESULTS: We included 43 patients [mean age 65.2 ± 13.8, median European System for Cardiac Operative Risk Evaluation II 1.8 (interquartile range 2.0)]. Twelve (27.9%) had prior cardiac surgery. Up to 90-day follow-up, no patient died and major morbidity was limited to 4 patients (9.3%) requiring pacemaker implantation and 1 patient requiring 2 reoperations. Within 1 year, 4 patients (9.3%) died. Nine patients (20.1%) required single readmission for cardiac reasons during the median follow-up of 38.4 months (interquartile range 30.9 months). All patients who survived beyond 1 year (n = 39) completed clinical follow-up. At follow-up, 38/39 (97.4%) patients were New York Heart Association I or II compared to 12/39 (30.8%) preoperatively (P = 0.001). The presence of oedema and intensity of diuretic treatment were significantly reduced (P = 0.005 and P = 0.008, respectively). Echocardiographic follow-up showed significant improvement of TV dysfunction in all patients. CONCLUSIONS: Our results suggest that isolated TV surgery can be performed safely and greatly improve patients' functional status. Our findings support the importance of optimal surgical timing and patient selection.
引用
- Weiss T, Villadsen PR, Jensen JK, et al. Outcomes of isolated tricuspid valve surgery in contemporary practice. Eur J Cardiothorac Surg. 2022. PMID: 35138382. doi:10.1093/ejcts/ezac077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。